Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Gut Butyrate on Blood Pressure in African Americans
NCT04415333Phase 1Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Jul 2021
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of sodium butyrate in hypertension (HTN) (3 arms), sponsored by University of North Carolina at Chapel Hill. Primary endpoints: Mean Daytime Blood Pressure and Mean Nighttime Blood Pressure. Started Jul 2021; status: completed.
02
Drugs
sodium butyrate
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT04415333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04415333.